These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11834744)

  • 21. Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) and peroxidase in macrophages, eosinophils, and extracellular matrix of the skin in the hypereosinophilic syndrome.
    Dvorak AM; Weller PF; Monahan-Earley RA; Letourneau L; Ackerman SJ
    Lab Invest; 1990 May; 62(5):590-607. PubMed ID: 2160562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) to intracytoplasmic crystals in tumor cells of primary solid and papillary epithelial neoplasm of the pancreas.
    Dvorak AM; Letourneau L; Weller PF; Ackerman SJ
    Lab Invest; 1990 May; 62(5):608-15. PubMed ID: 2160563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrastructural localization of Charcot-Leyden crystal protein in human eosinophils and basophils.
    Calafat J; Janssen H; Knol EF; Weller PF; Egesten A
    Eur J Haematol; 1997 Jan; 58(1):56-66. PubMed ID: 9020375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Charcot-Leyden crystal protein in the degranulation and recovery of activated basophils.
    Golightly LM; Thomas LL; Dvorak AM; Ackerman SJ
    J Leukoc Biol; 1992 Apr; 51(4):386-92. PubMed ID: 1373430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional analyses of placental protein 13/galectin-13.
    Than NG; Pick E; Bellyei S; Szigeti A; Burger O; Berente Z; Janaky T; Boronkai A; Kliman H; Meiri H; Bohn H; Than GN; Sumegi B
    Eur J Biochem; 2004 Mar; 271(6):1065-78. PubMed ID: 15009185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Localization of the human eosinophil Charcot-Leyden crystal protein (lysophospholipase) gene (CLC) to chromosome 19 and the human ribonuclease 2 (eosinophil-derived neurotoxin) and ribonuclease 3 (eosinophil cationic protein) genes (RNS2 and RNS3) to chromosome 14.
    Mastrianni DM; Eddy RL; Rosenberg HF; Corrette SE; Shows TB; Tenen DG; Ackerman SJ
    Genomics; 1992 May; 13(1):240-2. PubMed ID: 1577491
    [No Abstract]   [Full Text] [Related]  

  • 27. Differences between basophils and mast cells: failure to detect Charcot-Leyden crystal protein (lysophospholipase) and eosinophil granule major basic protein in human mast cells.
    Leiferman KM; Gleich GJ; Kephart GM; Haugen HS; Hisamatsu K; Proud D; Lichtenstein LM; Ackerman SJ
    J Immunol; 1986 Feb; 136(3):852-5. PubMed ID: 3510254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presence in human eosinophils of a lysophospholipase similar to that found in the pancreas.
    Holtsberg FW; Ozgur LE; Garsetti DE; Myers J; Egan RW; Clark MA
    Biochem J; 1995 Jul; 309 ( Pt 1)(Pt 1):141-4. PubMed ID: 7619049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Galectin-10, the protein that forms Charcot-Leyden crystals, is not stored in granules but resides in the peripheral cytoplasm of human eosinophils.
    Melo RCN; Wang H; Silva TP; Imoto Y; Fujieda S; Fukuchi M; Miyabe Y; Hirokawa M; Ueki S; Weller PF
    J Leukoc Biol; 2020 Jul; 108(1):139-149. PubMed ID: 32108369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils.
    Gleich GJ; Loegering DA; Mann KG; Maldonado JE
    J Clin Invest; 1976 Mar; 57(3):633-40. PubMed ID: 942977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Charcot-Leyden crystal protein and eosinophil granule major basic protein in sputum of patients with respiratory diseases.
    Dor PJ; Ackerman SJ; Gleich GJ
    Am Rev Respir Dis; 1984 Dec; 130(6):1072-7. PubMed ID: 6508005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium ionophore A23187 calcium-dependent cytolytic degranulation in human eosinophils.
    Fukuda T; Ackerman SJ; Reed CE; Peters MS; Dunnette SL; Gleich GJ
    J Immunol; 1985 Aug; 135(2):1349-56. PubMed ID: 3925008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation and sequence analysis of a cDNA encoding human placental tissue protein 13 (PP13), a new lysophospholipase, homologue of human eosinophil Charcot-Leyden Crystal protein.
    Than NG; Sumegi B; Than GN; Berente Z; Bohn H
    Placenta; 1999 Nov; 20(8):703-10. PubMed ID: 10527825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mRNA level of Charcot-Leyden crystal protein/galectin-10 is a marker for CRTH2 activation in human whole blood in vitro.
    Lin TA; Kourteva G; Hilton H; Li H; Tare NS; Carvajal V; Hang JS; Wei X; Renzetti LM
    Biomarkers; 2010 Nov; 15(7):646-54. PubMed ID: 20858065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Charcot-Leyden Crystal Protein in Nasal Secretions of Patients with Nonallergic Rhinitis with Eosinophilia Syndrome.
    Zhang M; Yan B; Wang Y; Wang C; Zhang L
    Int Arch Allergy Immunol; 2020; 181(11):888-896. PubMed ID: 32694242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Charcot-Leyden crystal protein/galectin-10 is a surrogate biomarker of eosinophilic airway inflammation in asthma.
    Nyenhuis SM; Alumkal P; Du J; Maybruck BT; Vinicky M; Ackerman SJ
    Biomark Med; 2019 Jun; 13(9):715-724. PubMed ID: 31157540
    [No Abstract]   [Full Text] [Related]  

  • 37. Charcot-Leyden Crystals in Eosinophilic Inflammation: Active Cytolysis Leads to Crystal Formation.
    Ueki S; Miyabe Y; Yamamoto Y; Fukuchi M; Hirokawa M; Spencer LA; Weller PF
    Curr Allergy Asthma Rep; 2019 Jun; 19(8):35. PubMed ID: 31203469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of eosinophils generated in vitro from CD34+ peripheral blood progenitor cells.
    Rosenberg HF; Dyer KD; Li F
    Exp Hematol; 1996 Jul; 24(8):888-93. PubMed ID: 8690047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional regulation of galectin-10 (eosinophil Charcot-Leyden crystal protein): a GC box (-44 to -50) controls butyric acid induction of gene expression.
    Dyer KD; Rosenberg HF
    Life Sci; 2001 Jun; 69(2):201-12. PubMed ID: 11441910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of detectability of Charcot-Leyden crystal protein transcripts in blood cells after treatment with dimethyl sulfoxide.
    Foell JL; Volkmer I; Giersberg C; Kornhuber M; Horneff G; Staege MS
    J Immunol Methods; 2008 Nov; 339(1):99-103. PubMed ID: 18789335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.